- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-GOLGA2/GM130
GOLGA2/GM130 Monoclonal Antibody for IF, WB, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat
Applications
WB, IF, ELISA
Conjugaison
Non conjugué
CloneNo.
2A4F11
N° de cat : 66662-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules LNCaP, cellules HEK-293, cellules HeLa, cellules HepG2, cellules HSC-T6, cellules Jurkat, cellules K-562, cellules PC-12 |
Résultats positifs en IF | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunofluorescence (IF) | IF : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 6 publications below |
Informations sur le produit
66662-1-Ig cible GOLGA2/GM130 dans les applications de WB, IF, ELISA et montre une réactivité avec des échantillons Humain, rat
Réactivité | Humain, rat |
Réactivité citée | rat, Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | GOLGA2/GM130 Protéine recombinante Ag1848 |
Nom complet | golgi autoantigen, golgin subfamily a, 2 |
Masse moléculaire calculée | 111 kDa |
Poids moléculaire observé | 130 kDa |
Numéro d’acquisition GenBank | BC014188 |
Symbole du gène | GOLGA2 |
Identification du gène (NCBI) | 2801 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
GOLGA2, also known as GM130, is a 130 kDa cis-Golgi matrix protein which is one component of the detergent and salt resistant Golgi matrix. It is a peripheral membrane protein highly bound to Golgi membrane and localized mainly at the cytoplasmic face of cis-Golgi membrane. Together with its interacting partner proteins, including p115, giantin, GRASP65, and Rab GTPase, GOLGA2/GM130 is involved in the regulation of ER-to-Golgi transport and also in the maintenance of the Golgi structure. Emerging evidence suggest that the GOLGA2/GM130 has potential roles in the control of glycosylation, cell cycle progression, and higher order cell functions such as cell polarization and directed cell migration. (PMID: 20197635)
Protocole
Product Specific Protocols | |
---|---|
WB protocol for GOLGA2/GM130 antibody 66662-1-Ig | Download protocol |
IF protocol for GOLGA2/GM130 antibody 66662-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
J Extracell Vesicles Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. | ||
Mol Metab CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. | ||
Front Mol Biosci Schwann Cell-Derived Exosomes Induce the Differentiation of Human Adipose-Derived Stem Cells Into Schwann Cells. | ||
Anticancer Drugs Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway | ||
Nat Commun Identification of indocyanine green as a STT3B inhibitor against mushroom α-amanitin cytotoxicity | ||
J Mater Sci Mater Med Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |